How are AVTR strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the AVTR strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 34.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$85.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a AVTR strangle?

The breakeven for the AVTR strangle priced on this page is roughly $12.15 and $14.85 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The AVTR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.86%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current AVTR implied volatility affect this strangle?

AVTR ATM IV is at 34.40% with IV rank near 6.45%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

AVTR Strangle Strategy

AVTR (Avantor, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services.

AVTR (Avantor, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $9.42B, a beta of 0.89 versus the broader market, a 52-week range of 7.265-15.93, average daily share volume of 10.2M, a public-listing history dating back to 2019, approximately 14K full-time employees. These structural characteristics shape how AVTR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.89 places AVTR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on AVTR?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

AVTR snapshot

As of August 14, 2026, spot at $13.68, ATM IV 34.40%, IV rank 6.45%, expected move 9.86%. The strangle on AVTR below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this strangle structure on AVTR specifically: AVTR IV at 34.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a AVTR strangle, with a market-implied 1-standard-deviation move of approximately 9.86% (roughly $1.35 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVTR expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVTR should anchor to the underlying notional of $13.68 per share and to the trader's directional view on AVTR stock.

AVTR strangle setup

The AVTR strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVTR at $13.68 on that close, the first option leg uses a $14.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVTR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVTR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$14.00	$0.43
Buy 1	Put	$13.00	$0.43

AVTR strangle risk and reward

Net Premium / Debit: -$85.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$85.00
Breakeven(s): $12.15, $14.85
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

AVTR strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on AVTR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$1,214.00
$3.03	-77.8%	+$911.64
$6.06	-55.7%	+$609.28
$9.08	-33.6%	+$306.91
$12.10	-11.5%	+$4.55
$15.13	+10.6%	+$27.81
$18.15	+32.7%	+$330.17
$21.18	+54.8%	+$632.53
$24.20	+76.9%	+$934.89
$27.22	+99.0%	+$1,237.26

When traders use strangle on AVTR

Strangles on AVTR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVTR chain.

AVTR thesis for this strangle

The market-implied 1-standard-deviation range for AVTR extends from approximately $12.33 on the downside to $15.03 on the upside. A AVTR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current AVTR IV rank near 6.45% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AVTR at 34.40%. As a Healthcare name, AVTR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVTR-specific events.

AVTR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVTR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVTR alongside the broader basket even when AVTR-specific fundamentals are unchanged. Always rebuild the position from current AVTR chain quotes before placing a trade.

Frequently asked questions

What is a strangle on AVTR?: A strangle on AVTR is the strangle strategy applied to AVTR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With AVTR stock at $13.68 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed AVTR chain strike and the premiums come straight from that session's bid/ask midpoint.
How are AVTR strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the AVTR strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 34.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$85.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AVTR strangle?: The breakeven for the AVTR strangle priced on this page is roughly $12.15 and $14.85 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The AVTR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.86%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on AVTR?: Strangles on AVTR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVTR chain.
How does current AVTR implied volatility affect this strangle?: AVTR ATM IV is at 34.40% with IV rank near 6.45%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.